A total of 1 in 6 new urticaria cases become chronic, with older age, higher BMI, and early prednisolone use identified as key predictors, researchers find.

An investigational once-weekly amylin receptor agonist conferred substantial weight loss across six different dosing regimens for adults with overweight or obesity, researchers reported in a phase 2 ...

The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month ...

Amylin is a peptide co-secreted with insulin in response to food intake. It controls gastric emptying, inhibits glucagon secretion, and promotes satiety. Several amylin receptor agonists are in ...

Weight-loss: Explore the complexities of obesity and why new GLP-1 medications are not a miracle cure. Learn about the ...

At first glance, YoungBoy Never Broke Again 's stage name reads more like a self-fulfilling prophecy than a rap moniker.

Is paying more than £300 for a full top-to-toe health check worth the money? Helen McGurk finds out with a visit to Randox ...

Patients with plateaued weight loss or who reached their weight-related goals on a GLP-1 receptor agonist were able to ...

In an analysis comparing bariatric surgery vs. obesity drugs in patients with diabetes and obesity, surgery was tied to lower ...

GLP-1RA use was associated with a lower incidence of rheumatic diseases such as rheumatoid arthritis, gout, and osteoarthritis relative to DPP-4is.

Novo Nordisk and Eli Lilly become latest drug companies to bend knee to Trump’s ‘most-favored nation’ pricing plan ...